pharmaceutical composition for treating cocaine addiction or preventing relapse of cocaine addiction, methods for treating cocaine addiction and for preventing cocaine addiction relapse, use of (r) -2- {3- [1- (5 -methyl-1,2,3,4-tetrahydronaphthalen-1-yl) piperidin-4-yl] -2,3-dihydro-2-oxo-benzimidazol-1-yl} -n-methylacetamide or a pharmaceutically acceptable salt thereof, and, (r) -2- {3- [1- (5-methyl-1,2,3,4-tetrahydronaphthalen-1-yl) piperidin-4-yl] -2, 3-dihydro-2-oxo-benzimidazol-1-yl} -n-methylacetamide or a pharmaceutically acceptable salt thereof.
The present invention provides a drug for treating cocaine dependence or preventing its relapse. Specifically, the present invention provides a drug for treating cocaine dependence or preventing its relapse containing (r) -2- {3- [1- (5-methyl-1,2,3,4-tetrahydronaphthalene). 1-yl]) piperidin-4-yl] -2,3-dihydro-2-oxo-benzimidazol-1-yl} -n-methylacetamide or a pharmaceutically acceptable salt thereof.a presente invenção provê um fármaco para tratar a dependência de cocaína ou prevenir a recaída da mesma. especificamente, a presente invenção provê um fármaco para tratar a dependência de cocaína ou prevenir a recaída da mesma contendo (r)-2-{3-[1-(5-metil-1,2,3,4-tetra-hidronaftalen-1-il])piperidina-4-il]-2,3-di-hidro-2-oxo-benzimidazol-1-il}-n-metilacetamida ou um sal farmaceuticamente aceitável do mesmo.
